Pharmaceuticals Reports
Explore In-Depth Reports on Pharmaceuticals. Offering Past Performance, Recent Statistics, and Future Revenue Prospects, These Reports Offer Precise Insights to Stay Ahead with Recent Industry Trends.
The immunotherapy drugs market size stood at USD 155.8 billion in 2024, and it is expected to grow at a CAGR of 5.2% during 2025–2032, to reach USD 231 billion by 2032. The immunotherapy drugs market is experiencing rapid growth due to key d...
The global osteoporosis drugs market was valued at USD 16.6 billion in 2024, and the market size is predicted to reach USD 25.4 billion by 2032, advancing at a CAGR of 5.6% during 2025–2032. The market is driven by increasing healthcare expendi...
The global pharmaceutical analytical testing outsourcing market size in 2024 is USD 9.4 billion, and it is expected to advance at a CAGR of 8.7% during 2025–2032, to reach USD 18.1 billion by 2032. This is ascribed to the innovations in the pha...
The global microbiome therapeutics market size in 2024 is USD 256.4 million, and it is expected to advance at a CAGR of 24.4% during the forecast period, to reach USD 1,450.2 million by 2032. The substantial role that the microbiome plays in gastroin...
The AI-based clinical trials solution market size stands at USD 2.4 billion in 2024, and it is expected to grow at a CAGR of 14.5% during 2025–2030, to reach USD 5.4 billion by 2030. The growth can be primarily ascribed to the increasing pre...
The global anti-vascular endothelial growth factor therapeutics market revenue will stand at an estimated USD 24.4 billion in 2024, and it is expected to advance at a CAGR of 3.8% during 2025–2030, to reach USD 30.5 billion by 2030. The growth ...
The global next-generation antibody therapeutics market stood at USD 2,686.2 million in 2024 and is expected to reach USD 4,139.1 million by 2030, advancing at a CAGR of 7.6% during 2025–2030. This will predominantly be due to advancements in m...
The custom peptide synthesis services market in the U.S. is projected to reach a value of USD 177.97 million in 2024, increasing to USD 270.94 million by 2030, with a compound annual growth rate of 7.8%. In contrast, the custom peptide synthesis serv...
The size of the Saudi Arabian pharmaceuticals market will be an estimated USD 21.8 billion in 2024, which is projected to grow at a CAGR of 4.5% from 2024 to 2030, reaching USD 28.3 billion by 2030. With the growing population in Saudi Arabia, hea...
Biopharmaceuticals Market Data The biopharmaceuticals market was valued at $448.1 billion in 2023, and it is expected to grow at a CAGR of 7.6% during 2024-2030, to reach $745.1 billion by 2030. With the growing incidence of chronic diseases li...
In-Silico Drug Discovery Market Analysis The global in-silico drug discovery market was valued at $2,829.7 million in 2023, and the market size is predicted to reach $5,691.4 million by 2030, advancing at a CAGR of 10.6% during 2024–2030. Th...
The global stem cell therapy market size was USD 306.1 million in 2023, and it is expected to reach USD 910.8 million in 2030, with a growth rate of 16.9% during 2024–2030. ...
The global drug discovery services market values an estimated USD 21.0 billion in 2023, which is expected to reach USD 54.2 billion by 2030, growing at a CAGR of 14.7% during 2024–2030. ...
The global pharmaceutical sterility testing market was valued at USD 1,959.9 million in 2024, which is expected to reach USD 3,763.0 million by 2030, growing at a CAGR of 11.5% during 2024–2030. This is owing to the expansion of biotechnologica...
The global clinical trial supplies market was valued at USD 4,369.2 million in 2024, and the market size is predicted to reach USD 7,763.9 million by 2030, advancing at a CAGR of 10.1% during 2024–2030. The key factors driving the growth of the...
The single-use assemblies market size stood at USD 2,869.7 million in 2024, and it is expected to grow at a CAGR of 15.7% during 2024–2030, to reach USD 6,901.5 million by 2030. The growth can be primarily ascribed to the rising adoption of ...
The global therapeutic drug monitoring market size was valued at USD 2,142.7 million in 2024, and this number is expected to increase to USD 3,764.1 million by 2030, advancing at a CAGR of 9.8% during 2024–2030. This is ascribed to the increasi...
The global vaccine adjuvants market was valued at USD 930.7 million in 2024, which is expected to reach USD 1,375.9 million by 2030, growing at a CAGR of 6.7% during 2024–2030. The growth is ascribed to the rising incidence of infectious illnes...
The pharmaceutical gelatin market size stood at USD 1,226.5 million in 2024, and it is expected to grow at a CAGR of 5.6% during 2024–2030, to reach USD 1,703.4 million by 2030. This is mainly attributed to the increasing need for pharmaceutica...
The global biologics CDMO market is estimated to have generated USD 17.1 billion in 2024, and it is predicted to reach USD 31.8 billion by 2030, advancing at a CAGR of 11.0% during 2024–2030. This is due to the surging incidence of chronic dise...
The neoantigen cancer vaccine market size was USD 48.7 million in 2024, and it is expected to reach USD 1,322.8 million in 2030, with a compound annual growth rate of 73.4% during 2024–2030. The major factors contributing toward the market a...
The U.S. and European Union osteoporosis drugs market is growing due to the increasing prevalence rate of osteoporosis diseases, the growing geriatric population, the surging cases of obesity, the rising prevalence of lifestyle-associated diseases, a...
The global empty capsules market generated revenue of USD 3,211.8 million in 2024, which is expected to witness a CAGR of 7.2% between 2024 and 2030, to reach USD 4,879 million by 2030. This can be ascribed to the growing adoption of encapsulate...
The global generic drugs market estimated to generate revenue of $404.3 billion in 2022, and it is expected to advance at a compound annual growth rate of 7.20% during 2022–2030, to reach $705.1 billion by 2030. ...
The global anticoagulants market size in 2021 was $21,736.2 million, and it is expected to advance at a CAGR of 7.8% during the forecast period, to reach $42,893.4 million by 2030. ...
The global active pharmaceutical ingredient (API) market generated $184,311.2 million revenue in 2020, and it is expected to grow at a CAGR of 6.9% during the forecast period (2021–2030). ...
The Asia-Pacific (APAC) gene therapy market valued $349.1 million in 2020, which is projected to progress at a CAGR of 36.8% during the forecast period (2021–2030). ...
The global psoriasis drugs market was valued at $14,504.0 million in 2020, which is projected to progress at a CAGR of 14.0% during the forecast period (2021–2030). ...
The global cosmeceuticals market is projected to showcase a strong growth during the forecast period (2021–2030), on account of increasing consumer awareness about cosmetics, and ageing population creating high demand for anti-ageing products. ...
The global dermatology drugs market was valued at $25,228.2 million in 2019, which is expected to progress at a CAGR of 8.8% during the forecast period (2020–2030). ...
The complementary and alternative medicines market revenue stood at $192.0 billion in 2018, and it is expected to progress at a CAGR of 6.0% during 2019–2024. ...
The biosimilars market size was $6.0 billion in 2018, and it is expected to advance at a CAGR of 29.6% during 2019–2024. ...
The global wet age-related macular degeneration (AMD) market is expected to generate revenue worth $10.4 billion in 2024, registering a CAGR of 7.1% during 2019–2024. The increasing prevalence of AMD, lack of availability of specific treatment,...
The global human insulin market valued $42.9 billion in 2017 and is projected to register a CAGR of 8.8% during the period 2018-2023, on account of the rising number of diabetic patients, growing geriatric population, technological advancements in in...
In the coming years, the medical marijuana market would observe considerable prosperity, due to the increasing incidence of chronic diseases, number of countries allowing the use of the substance for medication purposes, awareness of patients as w...
Age-related macular degeneration is a disorder that causes loss of vision in a person due to macula damage; macula is that part of an eye, which helps a person to see, it is made up of millions of light-sensing cells which provide sharp and central v...
Herpes is an infection caused by a virus known as, herpes simplex virus. It is estimated, that around 3.7 billion people under the age of 50 years are suffering with the herpes simplex virus infection, globally. The disease is categorized into two ty...
Amyotrophic lateral sclerosis is a disease that causes progression in neurodegeneration in brain and spinal cord. In Amyotrophic lateral sclerosis, the muscle does not get adequate nourishment due to which it becomes atrophic. The disease occurs in t...
Ewing sarcoma is a condition in which formation of cancer or tumor takes place in the bones and soft tissues. It is the second most common type of primary sarcoma found in young adults and children. Ewing sarcoma occurs in ribs, long bones, spine (ve...
The growing geriatric population and increasing demand of innovative and advanced pain relaxing medications around the world are the predominant growth drivers for the global pain management drugs market. Additionally, the increasing number of hospit...
The increase in research and development funds for drug discovery followed by growing awareness of kidney-related disorders, and diabetes are the major factors driving the expansion of the global diabetic nephropathy market. Globally, many programs a...
Pompe disease is a type of lysergic acid diethylamide (LSD). LSD refers to a group of diseases arising from the increase of specific substrates and is inherited autosomal recessive disorders. Lysergic acid diethylamide is progressive and having uneve...
Gastrointestinal diseases involve the gastrointestinal tract including stomach, esophagus, large intestine, small intestine, gallbladder, rectum, liver and pancreas. Over the counter (OTC) drugs are medications that are available without an...
Opioids are directed to the patients suffering from the acute and chronic non-cancer pain. The opioids have numerous adverse intestinal effects, such as opioid-induced constipation. The opioids also affect the discharge of digestive enzymes that can ...
Diabetic retinopathy refers to an eye disorder that damages or harms the blood vessels of the retina. Diabetic retinopathy can cause permanent blindness. Chronic diabetes is a major root of diabetic retinopathy. High glucose level in the blood can da...
One of the major trends noticed in the cytomegalovirus retinitis market is usage of off-label drugs for the treatment of cytomegalovirus retinitis. Innovation of products focusing on better efficacy, growing demographics and growing economies in the ...
Glaucoma is a disease of eye which is caused by excessive increase of fluid pressure within the eye. Glaucoma is caused due to mechanical compression or decreased blood flow in the optic nerve of the patient’s eye. If not treated properly, it m...
Asthma is a respiratory condition, where the airways become inflamed and narrow, which can cause a serious and incurable condition if left untreated. Breathlessness, wheezing and coughing are some of the symptoms of asthma and it can be controlled by...
Choroidal neovascular are the new blood vessels that grow just below the retina and interrupt the vision. Choroid, which is responsible for oxygen and nutrients supply to the eye, is the area between the retina and the sclera, where the blood vessels...